Cargando…

The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort Study

BACKGROUND: The indirect impact of the COVID-19 epidemic on major clinical outcomes of people with Parkinson's disease (PD) or other parkinsonism is unknown. OBJECTIVES: The study aimed to (1) describe changes in healthcare services during the first epidemic bout in people with PD or parkinsoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vignatelli, Luca, Baccari, Flavia, Belotti, Laura Maria Beatrice, Zenesini, Corrado, Baldin, Elisa, Calandra-Buonaura, Giovanna, Cortelli, Pietro, Descovich, Carlo, Giannini, Giulia, Guarino, Maria, Loddo, Giuseppe, Nassetti, Stefania Alessandra, Sambati, Luisa, Scaglione, Cesa, Trombetti, Susanna, D'Alessandro, Roberto, Nonino, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149301/ https://www.ncbi.nlm.nih.gov/pubmed/35651337 http://dx.doi.org/10.3389/fneur.2022.873925

Ejemplares similares

Risk of Hospitalization and Death for COVID‐19 in People with Parkinson's Disease or Parkinsonism
por: Vignatelli, Luca, et al.
Publicado: (2020)

Risk of SARS‐CoV‐2 infection, hospitalization, and death for COVID‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study
por: Zenesini, Corrado, et al.
Publicado: (2022)

The Treatment of Sleep Disorders in Parkinson’s Disease: From Research to Clinical Practice
por: Loddo, Giuseppe, et al.
Publicado: (2017)

Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes
por: Quadalti, Corinne, et al.
Publicado: (2021)

Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording
por: Calandra-Buonaura, Giovanna, et al.
Publicado: (2016)

Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
por: Baldelli, Luca, et al.
Publicado: (2021)

Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort
por: Contin, Manuela, et al.
Publicado: (2021)

The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population
por: Calandra-Buonaura, Giovanna, et al.
Publicado: (2020)

Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease
por: Zanigni, Stefano, et al.
Publicado: (2016)

How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Mathematical modeling and parameter estimation of levodopa motor response in patients with parkinson disease
por: Ursino, Mauro, et al.
Publicado: (2020)

A Mathematical Model of Levodopa Medication Effect on Basal Ganglia in Parkinson's Disease: An Application to the Alternate Finger Tapping Task
por: Baston, Chiara, et al.
Publicado: (2016)

Cognitive Profile and Its Evolution in a Cohort of Multiple System Atrophy Patients
por: Sambati, Luisa, et al.
Publicado: (2020)

Case report: Bilateral double beta peak activity is influenced by stimulation, levodopa concentrations, and motor tasks, in a Parkinson’s disease patient on chronic deep brain stimulation
por: Giannini, Giulia, et al.
Publicado: (2023)

Cognitive Function in Peripheral Autonomic Disorders
por: Guaraldi, Pietro, et al.
Publicado: (2014)

Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels
por: Cani, Ilaria, et al.
Publicado: (2022)

REM Sleep Behaviour Disorder in Multiple System Atrophy: From Prodromal to Progression of Disease
por: Giannini, Giulia, et al.
Publicado: (2021)

Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic Monitoring
por: Contin, Manuela, et al.
Publicado: (2022)

Risk of hospitalization and death for COVID‐19 in persons with epilepsy over a 20‐month period: The EpiLink Bologna cohort, Italy
por: Muccioli, Lorenzo, et al.
Publicado: (2022)

Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients
por: Zago, Elisa, et al.
Publicado: (2022)

Epigenetic clocks suggest accelerated aging in patients with isolated REM Sleep Behavior Disorder
por: Baldelli, Luca, et al.
Publicado: (2023)

Autonomic dysfunction in progressive supranuclear palsy
por: Baschieri, Francesca, et al.
Publicado: (2022)

L-Dopa Modulation of Brain Connectivity in Parkinson’s Disease Patients: A Pilot EEG-fMRI Study
por: Evangelisti, Stefania, et al.
Publicado: (2019)

TELEmedicine for EPIlepsy Care (TELE-EPIC): protocol of a randomised, open controlled non-inferiority clinical trial
por: Licchetta, Laura, et al.
Publicado: (2021)

Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31
por: Foschi, Matteo, et al.
Publicado: (2020)

Performing sleep studies after the COVID-19 outbreak: practical suggestions from Bologna's sleep unit
por: Cilea, Rosalia, et al.
Publicado: (2021)

Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis
por: Pondrelli, Federica, et al.
Publicado: (2021)

Peripheral nervous system adverse events associated with immune checkpoint inhibitors
por: Rossi, Simone, et al.
Publicado: (2023)

Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
por: Conti, Valeria, et al.
Publicado: (2022)

Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna’s Autonomic Unit
por: Guaraldi, Pietro, et al.
Publicado: (2020)

Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's disease
por: Mertens, Attakias T., et al.
Publicado: (2019)

Work Loss and Direct and Indirect Costs Associated with Parkinson’s Disease
por: Jerry, Michelle, et al.
Publicado: (2023)

Direct and indirect assessment of functional abilities in patients with Parkinson’s disease transitioning to dementia
por: de Oliveira, Gisele Saraiva Reis, et al.
Publicado: (2020)

Tracheostomy is associated with increased survival in Multiple System Atrophy patients with stridor
por: Giannini, Giulia, et al.
Publicado: (2022)

Parkinsonism hyperpyraexia syndrome in Parkinson's disease patients undergoing deep brain stimulation: An indirect consequence of COVID-19 lockdowns
por: Phokaewvarangkul, Onanong, et al.
Publicado: (2021)

Iodine-123-meta-iodobenzylguanidine Myocardial Scintigraphy in Isolated Autonomic Failure: Potential Red Flag for Future Multiple System Atrophy
por: Baschieri, Francesca, et al.
Publicado: (2017)

Diagnostic accuracy of quantitative susceptibility mapping in multiple system atrophy: The impact of echo time and the potential of histogram analysis
por: Lancione, Marta, et al.
Publicado: (2022)

Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR)
por: Ingravallo, Francesca, et al.
Publicado: (2020)

If seizures left speechless: CA-P-S C-A-R-E, a proposal of a new ictal language evaluation protocol
por: Ferri, Lorenzo, et al.
Publicado: (2020)

Cognitive and affective disorders in critical SARS-CoV-2 patients and caregivers
por: Sambati, Luisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p937c3jl396o6r19avbm6g4c8l